Results 1 to 10 of about 693,338 (390)
Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity [PDF]
Tumor necrosis factor alpha (TNF-α) is a proinflammatory cytokine that exerts both homeostatic and pathophysiological roles in the central nervous system.
Gabriel Olmos, Jerònia Lladó
doaj +7 more sources
Tumor Necrosis Factor Alpha Signaling and Organogenesis [PDF]
Tumor necrosis factor alpha (TNF-α) plays important roles in processes such as immunomodulation, fever, inflammatory response, inhibition of tumor formation, and inhibition of viral replication.
Kai You+4 more
doaj +3 more sources
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease. [PDF]
Alzheimer’s disease (AD) affects an estimated 44 million individuals worldwide, yet no therapeutic intervention is available to stop the progression of the dementia. Neuropathological hallmarks of AD are extracellular deposits of amyloid beta (Aβ) peptides assembled in plaques, intraneuronal accumulation of hyperphosphorylated tau protein forming ...
Boris Decourt, D. Lahiri, M. Sabbagh
semanticscholar +4 more sources
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
José Luis Callejas-Rubio, Lourdes López-Pérez, Norberto Ortego-CentenoUnit of Autoimmune Systemic Diseases, Hospital Clinico San Cecilio, Granada, SpainAbstract: Sarcoidosis is a chronic multisystem disease of unknown ...
José Luis Callejas-Rubio+2 more
doaj +6 more sources
Tumor necrosis factor alpha in sleep regulation.
This review details tumor necrosis factor alpha (TNF) biology and its role in sleep, and describes how TNF medications influence sleep/wake activity. Substantial evidence from healthy young animals indicates acute enhancement or inhibition of endogenous brain TNF respectively promotes and inhibits sleep.
M. Rockstrom+6 more
semanticscholar +6 more sources
Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
Glaucoma, a neurodegenerative disease, is currently being treated by modulation of one of its primary risk factors, the elevated intraocular pressure. Newer therapies that can provide direct neuroprotection to retinal ganglion cells are being extensively
Renu Agarwal, Puneet Agarwal
doaj +4 more sources
Tumor necrosis factor-alpha in patients with alopecia areata
Background : Alopecia areata (AA) is a common form of localized, nonscarring hair loss. It is characterized by the loss of hair in patches, total loss of scalp hair (alopecia totalis, AT), or total loss of body hair (alopecia universalis, AU).
Emina Kasumagic-Halilovic+2 more
doaj +4 more sources
Alopecia secondary to anti-tumor necrosis factor-alpha therapy [PDF]
Biologic drugs represent a substantial progress in the treatment of chronic inflammatory immunologic diseases. However, its crescent use has revealed seldom reported or unknown adverse reactions, mainly associated with anti-tumor necrosis factor (anti ...
Lara Beatriz Prata Ribeiro+5 more
doaj +6 more sources
Tumor Necrosis Factor-Alpha and Mast Cells: Revisited Study
Mast cells reside in connective tissues and are widely recognized as effector cells important in innate and acquired immunity. These cells are the only ones capable of storing preformed TNFα in their cytoplasmatic granules and release upon activation ...
A. Saggini+18 more
doaj +7 more sources
Tumor necrosis factor alpha inhibits signaling from the insulin receptor. [PDF]
Gökhan S. Hotamışlıgil+3 more
openalex +2 more sources